The American Diabetes Association, a voluntary health organization leading the fight to Stop Diabetes, has announced its officers and board of directors members for 2015.
The 2015 board of directors includes four principal officers, four elects and 10 at-large board members.
Janel Wright, JD, is chair of the board. Wright is chief of adjudications for the Alaska Department of Labor, Workers' Compensation Division, where she administers the statewide workers' compensation adjudication program and is responsible for the legal processes and adjudicative functions of the Division of Workers' Compensation and Alaska Workers' Compensation Board.
David G. Marrero, Ph.D., is president, Health Care & Education. Marrero is J.O. Ritchey Endowed professor of medicine and director, Diabetes Translational Research Center, at Indiana University School of Medicine. He has worked in diabetes education and research for more than 25 years.
Samuel Dagogo-Jack, M.D., is president, Medicine & Science. Dagogo-Jack is professor of medicine and director, division of Endocrinology, Diabetes and Metabolism, and director, Clinical Research Center at the University of Tennessee Health Science Center, Memphis, where he holds the A.C. Mullins Endowed Chair in Translational Research.
Richard Farber, MBA, is secretary/treasurer. Farber is a managing partner at McKendree Capital, an investment management company in Los Angeles.
Robin J. Richardson, is chair of the board-elect. Richardson is senior vice president of Moda Health, where he is the senior executive responsible for the company's integrated health systems, pharmacy, legislative, medicare and Medicaid programs as well as its human resources and facilities departments.
Margaret Powers, Ph.D., is president-elect, Health Care & Education. Powers is a research scientist at the International Diabetes Center where her research focuses on performance improvement with organizations and individuals to improve diabetes outcomes. She also is pioneering work with continuous glucose monitoring to study the glycemic effect of food.
Desmond Schatz, M.D., is president-elect, Medicine & Science. Schatz is the medical director of the Diabetes Center, professor and associate chairman of pediatrics and director of the Clinic Research Center at the University of Florida.
Lorrie Welker Liang is secretary/treasurer-elect. Liang is the vice president of Sinai Hospital of Baltimore, a member of the Lifebridge Health System. She is responsible for the overall financial, operational and strategic management for many of the hospital's departments.
At-large board members:
Brian Bertha, JD, MBA, is chief operating officer for Crescendo Bioscience in South San Francisco, Calif. He has responsibility for marketing, sales, manufacturing, information technology and business development.
David A. DeMarco, Ph.D., is a principal in Ernst & Young's (EY) advisory services practice and a member of the Global Life Sciences operating board.
Felicia Hill-Briggs, Ph.D., ABPP, is associate professor at the Johns Hopkins University School of Medicine, department of medicine, division of general internal medicine, and a core faculty member of the Welch Center for Prevention, Epidemiology, and Clinical Research.
Jeffrey Himmel is chairman and CEO of the Himmel Group, Himmel Pharmaceuticals and Himmel Media where he markets consumer health care brands, over-the-counter pharmaceuticals and health and nutrition products.
Alvin C. Powers, M.D., is the Joe C. Davis Chair in Biologic Science and professor of medicine, molecular physiology and biophysics at Vanderbilt University in Nashville.
Jane E.B. Reusch, M.D., is a professor of medicine at the University of Colorado at Denver and Health Sciences Center. She also is the director of the Diabetes Care Team at the Denver VA Medical Center.
Catherine Squires, CFRE, is vice president of development, Tufts Medical Center Trust, Tufts Medical Center and Floating Hospital for Children, Boston, Mass. In this position, she is the chief development executive for the medical center leading the growth of an annual fundraising program with a goal of $14 million and a comprehensive $150 million capital campaign.
Umesh Verma is founder, president and CEO of BLUE LANCE, a global provider of cybersecurity governance solutions that help companies save time and money via information security risk assessments, auditing and compliance automation.
Alan L. Yatvin, JD, is managing partner of the Philadelphia firm of Popper & Yatvin, where he concentrates his practice on police misconduct civil rights litigation, criminal defense in state and federal court, and representation of students with special needs, focusing on the rights and needs of those living with diabetes.